Time for Clinically Relevant Comparative Effectiveness Studies in Type 2 Diabetes

被引：6
|
作者：
Nathan, David M. [1 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2011年 / 154卷 / 02期
关键词：
TREATED PATIENTS; EXENATIDE; MELLITUS;
D O I：
10.7326/0003-4819-154-2-201101180-00303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / +
页数：2
相关论文
共 50 条
  • [31] THE ASSOCIATED COSTS OF TREATING TYPE 2 DIABETES PATIENTS TO A CLINICALLY RELEVANT COMPOSITE ENDPOINT WITH LIRAGLUTIDE VERSUS EXENATIDE
    Langer, J.
    Bouchard, J. R.
    VALUE IN HEALTH, 2012, 15 (04) : A176 - A176
  • [32] SMBG in Patients with Type 2 Diabetes without Insulin Therapy - Focus on Relevant Studies
    Braendle, M.
    Diem, P.
    Lehmann, R.
    Stettler, C.
    Faber-Heinemann, G.
    Heinemann, L.
    DIABETES STOFFWECHSEL UND HERZ, 2017, 26 (06): : 337 - 342
  • [33] A Systematic Review of the Comparative Effectiveness and Safety of SGLT2 Inhibitors in Type 2 Diabetes
    Tseng, Eva
    Bolen, Shari
    Segal, Jodi B.
    Wilson, Lisa
    Hutfless, Susan
    Maruthur, Nisa M.
    DIABETES, 2015, 64 : A661 - A662
  • [34] Dapagliflozin in type 2 diabetes: effectiveness across the spectrum of disease and over time
    Parikh, S.
    Wilding, J.
    Jabbour, S.
    Hardy, E.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (02) : 186 - 198
  • [35] Systematic Review: Comparative Effectiveness and Safety of Premixed Insulin Analogues in Type 2 Diabetes
    Qayyum, Rehan
    Bolen, Shari
    Maruthur, Nisa
    Feldman, Leonard
    Wilson, Lisa M.
    Marinopoulos, Spyridon S.
    Ranasinghe, Padmini
    Amer, Muhammed
    Bass, Eric B.
    ANNALS OF INTERNAL MEDICINE, 2008, 149 (08) : 549 - W106
  • [36] Comparative effectiveness of glucose, lipid, and blood-pressure lowering in type 2 diabetes
    Brown, JB
    Chan, W
    Russell, A
    Nichols, GA
    Weiss, T
    Alexander, C
    DIABETES, 2002, 51 : A271 - A271
  • [37] Comparative effectiveness and safety of empagliflozin on cardiovascular mortality and morbidity in adults with type 2 diabetes
    Aronow, Wilbert S.
    Shamliyan, Tatyana A.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
  • [38] Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus
    Bolen, Shari
    Feldman, Leonard
    Vassy, Jason
    Wilson, Lisa
    Yeh, Hsin-Chieh
    Marinopoulos, Spyriclon
    Wiley, Crystal
    Selvin, Elizabeth
    Wilson, Renee
    Bass, Eric B.
    Brancati, Frederick L.
    ANNALS OF INTERNAL MEDICINE, 2007, 147 (06) : 386 - 399
  • [39] Comparative Effectiveness of Patient Education Methods for Type 2 Diabetes A Randomized Controlled Trial
    Sperl-Hillen, Joann
    Beaton, Sarah
    Fernandes, Omar
    Von Worley, Ann
    Vazquez-Benitez, Gabriela
    Parker, Emily
    Hanson, Ann
    Lavin-Tompkins, Jodi
    Glasrud, Patricia
    Davis, Herbert
    Adams, Kenneth
    Parsons, William
    Spain, C. Victor
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (22) : 2001 - 2010
  • [40] Pathophysiological Phenotypes of Clinically Diagnosed Type 2 Diabetes
    Stidsen, Jacob V.
    Thomsen, Reimar W.
    Nielsen, Jens S.
    Rungby, Jorgen
    Ulrichsen, Sinna P.
    Berensci, Klara
    Friborg, Soren
    Brandslund, Ivan
    Nielsen, Aneta A.
    Christiansen, Jens S.
    Sorensen, Henrik
    Vaag, Allan A.
    Olesen, Thomas B.
    Olsen, Michael H.
    Henriksen, Jan Erik
    Beck-Nielsen, Henning
    DIABETES, 2014, 63 : A354 - A355
12345